SK

Soumya Kumari

Active Director Director DIN 10135195
DIN 10135195 First appointment Apr 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Soumya Kumari

Data last updated:

Soumya Kumari is a Director at Nysar Pharma Private Limited (since 2023). Nysar Pharma Private Limited reported revenue of ₹2.1 Lakh (FY 2024).

DIN 10135195
Primary Designation Director
First Appointment 26 Apr 2023
Oldest Company Age 3 yrs
Largest company Nysar Pharma Private Limited · ₹2.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nysar Pharma Private Limited U82990DL2023PTC413183
Director26 Apr 20232023₹2.1 Lakh (FY 2024)Active

Board colleagues of Soumya Kumari

NameDINCompanyDesignation
Shantanu Chaubey10135194Nysar Pharma Private LimitedDirector
Soni Kumari10135196Nysar Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nysar Pharma Private Limited
Premium access

Shareholding and investment profile for Soumya Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Soumya Kumari

Soumya Kumari currently holds 1 directorship: Nysar Pharma Private Limited (Director, since 26 Apr 2023, revenue ₹2.1 Lakh (FY 2024)).

Soumya Kumari was first appointed on 26 Apr 2023 as Director at Nysar Pharma Private Limited.

The current boards of Soumya Kumari's companies include Shantanu Chaubey (Nysar Pharma Private Limited), Soni Kumari (Nysar Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available